Sanger sequencing for quality control in AAV vector production

Whitepaper Clinical Studies Pharmaceutical Research and Development

thumbnail of content

Learn how Sanger sequencing QC workflow works with any Applied Biosystems™ genetic analyzer designed for fragment analysis.

Read now to explore:

Why AAV has become such a valuable commodity
Cloning an AAV vector plasmid in bacteria (Phase I)
Transformation into a finished recombinant AAV virus (Phase II)
Sequencing methods for AAV plasmid DNA quality control
Sanger sequencing of AAV plasmid DNA

Sign up to our content service and access now

Your company email address

Please select your industry: (max 1)
Which technology is of interest? (max 1)
Would you like to request a demo? (max 1)

Opt In?

By you requesting this resource, you agree to our terms of use. All data is protected by our Privacy Notice. You can change your contact preferences here. If you have any further questions please get in contact.
Citeline (previously Pharma Intelligence UK) may contact me with updates, relevant promotions and information about products. My Information will be used in accordance with the Citeline Privacy Policy, and you withdraw your permission to receive any of our communications at any time.
Thermo Fisher Scientific (including its affiliates) may contact me about events, products, services and promotions which Thermo Fisher believes may be of interest to me via email and will process my Personal Information according to its privacy policy. I can withdraw my consent and unsubscribe at any time by e-mailing reply@thermofisher.com. I acknowledge Thermo Fisher Scientific (including its affiliates) will process my Personal Information according to its Privacy Policy, which includes information about my rights

Explore similar content

thumbnail of the content

Resiliency and innovation - Navigating the current biotech landscape

Gain insight from ICON’s Biotech President, Chris Smyth, on the biggest barriers to success in biotech, and the key strategies required to survive and thrive in this dynamic and competitive landscape. Download the article to gain perspective on the:

Article Clinical Studies Pharmaceutical Research and Development

thumbnail of the content

Immune checkpoint inhibitors: A breakthrough for immunotherapy

Immune checkpoint inhibitors (ICIs) have shown their efficacy, not only as a standalone treatment, but also when combined with traditional methods like chemotherapy and radiation. However, persistent challenges such as high costs and regulatory hurdles still exist. Gain expert knowledge on this novel approach to cancer therapy, with key topics including:

Whitepaper Clinical Studies Pharmaceutical Research and Development

thumbnail of the content

HIV – Global Clinical Trial Landscape

Explore the far-reaching impact of HIV, the latest global research priorities, and the innovative treatments, such as Antiretroviral therapy (ART), that offer hope in finding a cure. Gain insights from CRO experts, Novotech, on key topics, such as:

Report Clinical Studies Pharmaceutical Research and Development